In a blinded , randomized , three-arm placebo-controlled clinical trial , @ participants with diabetic nephropathy taking lisinopril ( @ mg ) were randomized to spironolactone ( @ mg daily ) , losartan ( @ mg daily ) , or placebo ( trial dates from July of @ to December of @ ) .